GlassScriptPhysician profile
Marleigh Essler
NPI 1568163673
$2,302.37
in general payments reported to CMS, 2019-2025
17 companies · $1,770 in 2025
The $1,770 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $532 · 2025: $1,770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,302.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $568.21 | 2024-2025 | Cabenuva, Dovato, Apretude |
| Paratek Pharmaceuticals, INC. | $222.78 | 2024-2025 | Nuzyra |
| Insmed, INC. | $203.05 | 2025 | Arikayce, Brinsupri |
| Merck Sharp & Dohme LLC | $192.09 | 2024-2025 | Zerbaxa, Prevymis, Delstrigo |
| Abbvie INC. | $186.82 | 2024-2025 | |
| Shionogi INC | $185.55 | 2024-2025 | Fetroja |
| Aimmune Therapeutics, INC. | $168.72 | 2024-2025 | Vowst, Zenpep |
| La Jolla Pharmaceutical Company | $107.45 | 2025 | Zevtera, Xacduro |
| Takeda Pharmaceuticals U.S.A., INC. | $95.09 | 2024-2025 | Livtencity |
| Melinta Therapeutics, LLC | $79.14 | 2024-2025 | Rezzayo, Kimyrsa, Orbactiv |
| Cumberland Pharmaceuticals, INC. | $73.69 | 2025 | Vibativ |
| Emd Serono, INC. | $61.03 | 2024 | |
| Theratechnologies INC. | $55.24 | 2024-2025 | Trogarzo, Egrifta |
| Ferring Pharmaceuticals INC. | $32.22 | 2025 | Rebyota |
| Kamada LTD. | $25.19 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $23.99 | 2025 | |
| Octapharma USA, INC. | $22.11 | 2025 | Panzyga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marleigh Essler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.